'Unapproved drugs' diaporamas de présentation

Empowerment of Terminally Ill Research Subjects

Empowerment of Terminally Ill Research Subjects. Uniformed Services University of the Health Sciences February 10, 2014. Lauren Solberg, JD, MTS Assistant Professor, Program in Bioethics, Law & Medical Professionalism Department of Community Health & Family Medicine;

751 views • 59 slides

Behind the Veil of Cancer :

Behind the Veil of Cancer :. Truth , Options, & the Secrets to why there is no cure. Disclaimer:

604 views • 37 slides

UCD Human Research Protection Program Accreditation

UC DAVIS OFFICE OF RESEARCH. UCD Human Research Protection Program Accreditation. Miles McFann Nicole Walters IRB Administration Outreach, Training, and Education. Objectives. AAHRPP Benefits of Accreditation Where Are We In The Process Faculty and Staff Preparation

466 views • 31 slides

The Marketed Unapproved Drugs Initiative

The Marketed Unapproved Drugs Initiative. CDR Lori Cantin, R.Ph., Pharm.D. Marketed Unapproved Drugs Enforcement Team Office of Unapproved Drugs and Labeling Compliance (OUDLC) Office of Compliance (OC) Center for Drug Evaluation and Research (CDER) U.S. Food and Drug Administration

652 views • 30 slides

Pharmaceutical Shortages: Impact on Patients, Professionals and the Public

396 views • 29 slides

Overview of FDA's Regulatory Compliance Agenda

Overview of FDA's Regulatory Compliance Agenda. Daniel Meron, Esq. General Counsel Department of Health and Human Services August 22, 2007. Topics. Regulation of Drug Compounding Enforcement Regarding Unapproved Drugs Off-Label Promotion Investigations and Enforcement Preemption.

203 views • 10 slides

Surveillance Update GADA/CVM Meeting

Surveillance Update GADA/CVM Meeting. Neal Bataller, ME, DVM Division of Surveillance FDA/Center for Veterinary Medicine. Organizational Changes. Division of Surveillance ~ Has Now Become ~ Division of Surveillance Division of Veterinary Product Safety.

188 views • 6 slides